Lever Bio
ID: 17836029Lever Bio is a developer of immuno-oncology therapies founded in 2023 by Enrico Giraudo, Massimiliano Mazzone, Teresa Manzo and Guido Serini.
2
Funding Rounds
$10.5m
Money raised
Recent Funding Rounds
Overview
Lever Bio is a developer of immuno-oncology therapies founded in 2023 by Enrico Giraudo, Massimiliano Mazzone, Teresa Manzo and Guido Serini.
- Website:
- Headquarters: Turin
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| En**** Gi***** |
|
- | |
| Ma********** Ma***** |
|
- | |
| Te**** Ma*** | - | - | |
| Gu*** Se**** |
|
- |
Funding series
Funding Series Analysis
The company Lever Bio has raised a total of $10.5m in funding over 2 rounds.
Key Insights:
- Lever Bio Seed Round, December 2025: $6m
- Lever Bio Seed Round, May 2025: $4.5m